RNASEL and MIR146A SNP-SNP Interaction As a Susceptibility Factor for Non-melanoma Skin Cancer

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2014 Apr 5

PMID 24699816

Citations 13

Authors

Shohreh F Farzan

Margaret R Karagas

Brock C Christensen

Zhongze Li

Jacquelyn K Kuriger

Heather H Nelson

Affiliations

Soon will be listed here.

Abstract

Immunity and inflammatory pathways are important in the genesis of non-melanoma skin cancers (NMSC). Functional genetic variation in immune modulators has the potential to affect disease etiology. We investigated associations between common variants in two key regulators, MIR146A and RNASEL, and their relation to NMSCs. Using a large population-based case-control study of basal cell (BCC) and squamous cell carcinoma (SCC), we investigated the impact of MIR146A SNP rs2910164 on cancer risk, and interaction with a SNP in one of its putative targets (RNASEL, rs486907). To examine associations between genotype and BCC and SCC, occurrence odds ratios (OR) and 95% confidence intervals (95%CI) were calculated using unconditional logistic regression, accounting for multiple confounding factors. We did not observe an overall change in the odds ratios for SCC or BCC among individuals carrying either of the RNASEL or MIR146A variants compared with those who were wild type at these loci. However, there was a sex-specific association between BCC and MIR146A in women (ORGC = 0.73, [95%CI = 0.52-1.03]; ORCC = 0.29, [95% CI = 0.14-0.61], p-trend<0.001), and a reduction in risk, albeit not statistically significant, associated with RNASEL and SCC in men (ORAG = 0.88, [95%CI = 0.65-1.19]; ORAA = 0.68, [95%CI = 0.43-1.08], p-trend = 0.10). Most striking was the strong interaction between the two genes. Among individuals carrying variant alleles of both rs2910164 and rs486907, we observed inverse relationships with SCC (ORSCC = 0.56, [95%CI = 0.38-0.81], p-interaction = 0.012) and BCC (ORBCC = 0.57, [95%CI = 0.40-0.80], p-interaction = 0.005). Our results suggest that genetic variation in immune and inflammatory regulators may influence susceptibility to NMSC, and novel SNP-SNP interaction for a microRNA and its target. These data suggest that RNASEL, an enzyme involved in RNA turnover, is controlled by miR-146a and may be important in NMSC etiology.

Citing Articles

Hormonal interventions in skin wounds - a mini review.

Li Z, Ma R, Tan J, Li C, Xiao Y, Qiu X Mol Med. 2024; 30(1):217.

PMID: 39543465 PMC: 11566089. DOI: 10.1186/s10020-024-00978-6.

Human Melanoma Cells Differentially Express RNASEL/RNase-L and miR-146a-5p under Sex Hormonal Stimulation.

Orlandi E, De Tomi E, Campagnari R, Belpinati F, Rodolfo M, Vergani E Curr Issues Mol Biol. 2022; 44(10):4790-4802.

PMID: 36286041 PMC: 9601115. DOI: 10.3390/cimb44100326.

Is miRNA Regulation the Key to Controlling Non-Melanoma Skin Cancer Evolution?.

Tamas T, Baciut M, Nutu A, Bran S, Armencea G, Stoia S Genes (Basel). 2021; 12(12).

PMID: 34946878 PMC: 8701953. DOI: 10.3390/genes12121929.

Risk prediction models for intensive care unit-acquired weakness in intensive care unit patients: A systematic review.

Zhang W, Tang Y, Liu H, Yuan L, Wang C, Chen S PLoS One. 2021; 16(9):e0257768.

PMID: 34559850 PMC: 8462700. DOI: 10.1371/journal.pone.0257768.

Sex-specific differences in patients with nonmelanoma skin cancer of the pinna.

Moser U, Andrianakis A, Pondorfer P, Wolf A, Graupp M, Weiland T Head Neck. 2020; 42(9):2414-2420.

PMID: 32369257 PMC: 7496743. DOI: 10.1002/hed.26237.

References

Zhang L, Mi Y, Qin C, Wang Y, Cao Q, Wei J . RNASEL -1385G/A polymorphism and cancer risk: a meta-analysis based on 21 case-control studies. Mol Biol Rep. 2011; 38(8):5099-105. DOI: 10.1007/s11033-010-0657-2. View

Nguyen L, Espert L, Mechti N, Wilson 3rd D . The human interferon- and estrogen-regulated ISG20/HEM45 gene product degrades single-stranded RNA and DNA in vitro. Biochemistry. 2001; 40(24):7174-9. DOI: 10.1021/bi010141t. View

Jazdzewski K, Murray E, Franssila K, Jarzab B, Schoenberg D, de la Chapelle A . Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2008; 105(20):7269-74. PMC: 2438239. DOI: 10.1073/pnas.0802682105. View

Chen A, Halliday G, Damian D . Non-melanoma skin cancer: carcinogenesis and chemoprevention. Pathology. 2013; 45(3):331-41. DOI: 10.1097/PAT.0b013e32835f515c. View

Welsh M, Karagas M, Applebaum K, Spencer S, Perry A, Nelson H . A role for ultraviolet radiation immunosuppression in non-melanoma skin cancer as evidenced by gene-environment interactions. Carcinogenesis. 2008; 29(10):1950-4. PMC: 2556967. DOI: 10.1093/carcin/bgn160. View

Pentecost B . Expression and estrogen regulation of the HEM45 MRNA in human tumor lines and in the rat uterus. J Steroid Biochem Mol Biol. 1998; 64(1-2):25-33. DOI: 10.1016/s0960-0760(97)00140-4. View

Hassel B, Zhou A, Sotomayor C, Maran A, Silverman R . A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J. 1993; 12(8):3297-304. PMC: 413597. DOI: 10.1002/j.1460-2075.1993.tb05999.x. View

Euvrard S, Kanitakis J, Claudy A . Skin cancers after organ transplantation. N Engl J Med. 2003; 348(17):1681-91. DOI: 10.1056/NEJMra022137. View

Fesinmeyer M, Kwon E, Fu R, Ostrander E, Stanford J . Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study. Prostate. 2011; 71(14):1538-47. PMC: 3130811. DOI: 10.1002/pros.21370. View

10.

Yue C, Wang M, Ding B, Wang W, Fu S, Zhou D . Polymorphism of the pre-miR-146a is associated with risk of cervical cancer in a Chinese population. Gynecol Oncol. 2011; 122(1):33-7. DOI: 10.1016/j.ygyno.2011.03.032. View

11.

Kruger S, Engel C, Bier A, Silber A, Gorgens H, Mangold E . The additive effect of p53 Arg72Pro and RNASEL Arg462Gln genotypes on age of disease onset in Lynch syndrome patients with pathogenic germline mutations in MSH2 or MLH1. Cancer Lett. 2007; 252(1):55-64. DOI: 10.1016/j.canlet.2006.12.006. View

12.

Andersen J, Li X, Judge C, Zhou A, Jha B, Shelby S . Role of 2-5A-dependent RNase-L in senescence and longevity. Oncogene. 2006; 26(21):3081-8. DOI: 10.1038/sj.onc.1210111. View

13.

Orsos Z, Szanyi I, Csejtei A, Gerlinger I, Ember I, Kiss I . Association of pre-miR-146a rs2910164 polymorphism with the risk of head and neck cancer. Anticancer Res. 2012; 33(1):341-6. View

14.

Chatzikyriakidou A, Voulgari P, Georgiou I, Drosos A . A polymorphism in the 3'-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility. Joint Bone Spine. 2010; 77(5):411-3. DOI: 10.1016/j.jbspin.2010.05.013. View

15.

Andersson K, Michael K, Luostarinen T, Waterboer T, Gislefoss R, Hakulinen T . Prospective study of human papillomavirus seropositivity and risk of nonmelanoma skin cancer. Am J Epidemiol. 2012; 175(7):685-95. DOI: 10.1093/aje/kwr373. View

16.

Madsen B, Ramos E, Boulard M, Duda K, Overgaard J, Nordsmark M . Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer. PLoS One. 2008; 3(6):e2492. PMC: 2424240. DOI: 10.1371/journal.pone.0002492. View

17.

Lindelof B, Sigurgeirsson B, Gabel H, Stern R . Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol. 2000; 143(3):513-9. View

18.

Etzrodt M, Cortez-Retamozo V, Newton A, Zhao J, Ng A, Wildgruber M . Regulation of monocyte functional heterogeneity by miR-146a and Relb. Cell Rep. 2012; 1(4):317-24. PMC: 3334310. DOI: 10.1016/j.celrep.2012.02.009. View

19.

Yin Z, Yan L, Cui Z, Li X, Ren Y, Zhou B . Effects of common polymorphisms rs2910164 in miR-146a and rs3746444 in miR-499 on cancer susceptibility: a meta-analysis. Mol Biol Rep. 2013; 40(4):3003-13. DOI: 10.1007/s11033-012-2372-7. View

20.

Zhou F, Zhu H, Luo D, Wang M, Dong X, Hong Y . A functional polymorphism in Pre-miR-146a is associated with susceptibility to gastric cancer in a Chinese population. DNA Cell Biol. 2012; 31(7):1290-5. DOI: 10.1089/dna.2011.1596. View